Correction to: Rozanolixizumab: First Approval
Drugs
.
2023 Nov;83(16):1569.
doi: 10.1007/s40265-023-01960-y.
Author
Sheridan M Hoy
1
Affiliation
1
Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand. dru@adis.com.
PMID:
37861882
PMCID:
PMC10624700
DOI:
10.1007/s40265-023-01960-y
No abstract available
Publication types
Published Erratum